2024-08-01 2025-07-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 12729075 bus:FullAccounts 2024-08-01 2025-07-31 12729075 bus:Micro-entities 2024-08-01 2025-07-31 12729075 bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 12729075 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 12729075 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 12729075 2024-08-01 2025-07-31 12729075 2025-07-31 12729075 bus:RegisteredOffice 2024-08-01 2025-07-31 12729075 core:WithinOneYear 2025-07-31 12729075 core:AfterOneYear 2025-07-31 12729075 2023-08-01 12729075 bus:Director1 2024-08-01 2025-07-31 12729075 bus:Director1 2025-07-31 12729075 bus:Director1 2023-08-01 2024-07-31 12729075 bus:CompanySecretary1 2024-08-01 2025-07-31 12729075 bus:LeadAgentIfApplicable 2024-08-01 2025-07-31 12729075 2023-08-01 2024-07-31 12729075 2024-07-31 12729075 core:WithinOneYear 2024-07-31 12729075 core:AfterOneYear 2024-07-31 12729075 bus:EntityAccountantsOrAuditors 2023-08-01 2024-07-31 12729075 core:CostValuation core:Non-currentFinancialInstruments 2025-07-31 12729075 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 12729075 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-07-31 12729075 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12729075 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12729075 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12729075 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-07-31 12729075 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-07-31 12729075 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12729075 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12729075 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12729075 core:Non-currentFinancialInstruments 2025-07-31 12729075 core:Non-currentFinancialInstruments 2024-07-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12729075
England and Wales

 

 

 


Unaudited Financial Statements

for the year ended 31 July 2025

for

WREN GOODS LTD

 
 
 
£
2025
£
   
£
2024
£
Current assets 149  218 
Creditors: amount falling due within one year (10,725) (9,497)
Net current assets/(liabilities) (10,576) (9,279)
Total assets less current liabilities (10,576) (9,279)
Net assets/(liabilities) (10,576) (9,279)
 
Capital and reserves (10,576) (9,279)
 



Notes to the Accounts
Statutory Information
Wren Goods Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 12729075, registration address 21 Shelley Drive, Cheadle, Stoke-On-Trent, ST10 1XR, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 0 (2024: 0).

Director's Responsibilities:
  1. For the year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions.

Signed on behalf of the board of directors:


---------------------------------------------
Jacob Thomas Baker
Director

Date approved: 25 July 2026
1